Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KDNY | ZTS | TAK | UTHR | NBIX |
| Company | Chinook Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 40.31 | 146.25 | 13.37 | 235.23 | 141.00 |
| High | 40.51 | 149.90 | 13.41 | 240.00 | 145.00 |
| Low | 40.30 | 145.18 | 13.30 | 234.16 | 139.22 |
| Last | 40.39 | 149.56 | 13.38 | 234.47 | 140.09 |
| Change | +0.09 | +4.02 | +0.02 | +0.41 | +6.43 |
| % Change | +0.22% | +2.76% | +0.15% | +0.18% | +4.81% |
| Volume | 4,924,900 | 4,315,200 | 1,702,400 | 521,300 | 1,607,800 |
| 20-Day Average Volume | 2,629,690 | 4,148,760 | 1,820,815 | 536,845 | 797,445 |
| Previous Close | 40.30 | 145.54 | 13.36 | 234.06 | 133.66 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 39.61 | 159.40 | 13.54 | 235.18 | 136.67 |
| 20-Day Raw Stochastic | 92.73% | 18.07% | 20.15% | 44.07% | 66.98% |
| 20-Day Relative Strength | 77.95% | 32.61% | 39.08% | 50.79% | 55.97% |
| Weighted Alpha | +55.60 | -21.01 | -19.42 | +3.51 | +41.20 |
| Today's Opinion | 100% Buy | 88% Sell | 100% Sell | 64% Buy | 96% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 100% Sell | 64% Buy | 56% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 56% Sell | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.25% since 08/03/23 | -2.26% since 04/16/24 | +1.13% since 04/16/24 | +1.16% since 04/16/24 | +5.34% since 04/16/24 |
| Low | 40.25 on 08/04/23 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 232.84 on 04/17/24 | 130.13 on 04/19/24 |
| High | 40.51 on 08/10/23 | 153.67 on 04/18/24 | 13.41 on 04/23/24 | 240.74 on 04/18/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | +3.30% since 07/10/23 | -11.45% since 03/22/24 | -7.15% since 03/22/24 | -1.44% since 03/22/24 | -0.95% since 03/22/24 |
| Low | 38.86 on 07/21/23 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 221.53 on 04/01/24 | 130.13 on 04/19/24 |
| High | 40.51 on 08/10/23 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 250.89 on 03/26/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | +74.62% since 05/10/23 | -20.49% since 01/23/24 | -9.16% since 01/23/24 | +7.66% since 01/23/24 | -0.23% since 01/23/24 |
| Low | 19.20 on 05/16/23 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 40.51 on 08/10/23 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +67.39% since 02/10/23 | -10.17% since 10/23/23 | -7.85% since 10/23/23 | +4.60% since 10/23/23 | +29.82% since 10/23/23 |
| Low | 18.34 on 05/02/23 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 103.63 on 11/10/23 |
| High | 40.51 on 08/10/23 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 258.31 on 12/14/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,900,204 | 66,564,024 | 42,281,968 | 11,014,628 | 13,300,106 |
| Shares Outstanding, K | 71,805 | 457,359 | 3,164,818 | 47,059 | 99,507 |
| Annual Sales | 6,130,000 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -187,870,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 1,830,000 | 2,213,000,000 | 7,556,070,000 | 614,700,000 | 515,200,000 |
| Last Quarter Net Income | -60,180,000 | 525,000,000 | 718,900,000 | 217,100,000 | 147,700,000 |
| 60-Month Beta | 0.34 | 0.85 | 0.53 | 0.52 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.94 on 08/07/23 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 4.36 on 02/21/24 | 1.44 on 02/07/24 |
| Latest Earnings Date | 08/14/23 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.54 | 6.79 | 11.99 | 54.55 |